TELA Bio

TELA Bio Introduces Revolutionary Hernia Mesh Fixation Devices in the U.S., Aiming to Transform Surgical Practices

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leader in the development of medical devices for soft tissue reconstruction, has made a significant stride in surgical innovation with the …

TELA Bio Introduces Revolutionary Hernia Mesh Fixation Devices in the U.S., Aiming to Transform Surgical Practices Read More
Vishay Intertechnology

Vishay Introduces New Panel Potentiometers with Integrated Knobs, Enhancing Industrial and Audio Applications

MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), a global leader in discrete semiconductors and passive electronic components, announced the recent launch of its latest innovations in panel potentiometers, the …

Vishay Introduces New Panel Potentiometers with Integrated Knobs, Enhancing Industrial and Audio Applications Read More

Annovis Bio

Annovis Bio Nears Milestone in Alzheimer’s Treatment Study with Completion of Data Cleaning

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biotech firm focused on developing novel treatments for neurodegenerative diseases, announced the successful completion of data cleaning for its pivotal phase …

Annovis Bio Nears Milestone in Alzheimer’s Treatment Study with Completion of Data Cleaning Read More


Vishay Intertechnology

Vishay Intertechnology Boosts Infrared Transceiver Capabilities Amid Growing Demand for Wireless Data Transmission

MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has announced significant upgrades to its TFBS4xx and TFDU4xx series of infrared (IR) transceiver modules for IrDA® applications. The enhancements include a …

Vishay Intertechnology Boosts Infrared Transceiver Capabilities Amid Growing Demand for Wireless Data Transmission Read More
Ocugen

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon

MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More